 | • レポートコード：GIR-105X03359 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、カルフィルゾミブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カルフィルゾミブの種類別市場規模（10mg注射、30mg注射、60mg注射）、用途別市場規模（病院、クリニック、ドラッグセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・カルフィルゾミブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Natco、AstraZeneca ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10mg注射、30mg注射、60mg注射 ・用途別分析2016年-2026年：病院、クリニック、ドラッグセンター、その他 ・カルフィルゾミブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・カルフィルゾミブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・カルフィルゾミブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・カルフィルゾミブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・カルフィルゾミブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Carfilzomib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Carfilzomib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Carfilzomib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Carfilzomib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10mg Injection
30mg Injection
60mg Injection
Market segment by Application can be divided into
Hospital
Clinic
Drug Center
Other
The key market players for global Carfilzomib market are listed below:
Amgen
Natco
AstraZeneca
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Carfilzomib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carfilzomib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10mg Injection
1.2.3 30mg Injection
1.2.4 60mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Carfilzomib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Carfilzomib Market Size & Forecast
1.4.1 Global Carfilzomib Sales in Value (2016-2026))
1.4.2 Global Carfilzomib Sales in Volume (2016-2026)
1.4.3 Global Carfilzomib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Carfilzomib Production Capacity Analysis
1.5.1 Global Carfilzomib Total Production Capacity (2016-2026)
1.5.2 Global Carfilzomib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carfilzomib Market Drivers
1.6.2 Carfilzomib Market Restraints
1.6.3 Carfilzomib Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Carfilzomib Product and Services
2.1.4 Amgen Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Natco
2.2.1 Natco Details
2.2.2 Natco Major Business
2.2.3 Natco Carfilzomib Product and Services
2.2.4 Natco Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Carfilzomib Product and Services
2.3.4 AstraZeneca Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Carfilzomib Sales by Manufacturer
3.1 Global Carfilzomib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Carfilzomib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Carfilzomib
3.4 Market Concentration Rate
3.4.1 Top 3 Carfilzomib Manufacturer Market Share
3.4.2 Top 6 Carfilzomib Manufacturer Market Share
3.5 Global Carfilzomib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Carfilzomib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carfilzomib Market Size by Region
4.1.1 Global Carfilzomib Sales in Volume by Region (2016-2026)
4.1.2 Global Carfilzomib Revenue by Region (2016-2026)
4.2 North America Carfilzomib Revenue (2016-2026)
4.3 Europe Carfilzomib Revenue (2016-2026)
4.4 Asia-Pacific Carfilzomib Revenue (2016-2026)
4.5 South America Carfilzomib Revenue (2016-2026)
4.6 Middle East and Africa Carfilzomib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Carfilzomib Sales in Volume by Type (2016-2026)
5.2 Global Carfilzomib Revenue by Type (2016-2026)
5.3 Global Carfilzomib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Carfilzomib Sales in Volume by Application (2016-2026)
6.2 Global Carfilzomib Revenue by Application (2016-2026)
6.3 Global Carfilzomib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Carfilzomib Sales by Type (2016-2026)
7.2 North America Carfilzomib Sales by Application (2016-2026)
7.3 North America Carfilzomib Market Size by Country
7.3.1 North America Carfilzomib Sales in Volume by Country (2016-2026)
7.3.2 North America Carfilzomib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Carfilzomib Sales by Type (2016-2026)
8.2 Europe Carfilzomib Sales by Application (2016-2026)
8.3 Europe Carfilzomib Market Size by Country
8.3.1 Europe Carfilzomib Sales in Volume by Country (2016-2026)
8.3.2 Europe Carfilzomib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Carfilzomib Sales by Type (2016-2026)
9.2 Asia-Pacific Carfilzomib Sales by Application (2016-2026)
9.3 Asia-Pacific Carfilzomib Market Size by Region
9.3.1 Asia-Pacific Carfilzomib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Carfilzomib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Carfilzomib Sales by Type (2016-2026)
10.2 South America Carfilzomib Sales by Application (2016-2026)
10.3 South America Carfilzomib Market Size by Country
10.3.1 South America Carfilzomib Sales in Volume by Country (2016-2026)
10.3.2 South America Carfilzomib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carfilzomib Sales by Type (2016-2026)
11.2 Middle East & Africa Carfilzomib Sales by Application (2016-2026)
11.3 Middle East & Africa Carfilzomib Market Size by Country
11.3.1 Middle East & Africa Carfilzomib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Carfilzomib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Carfilzomib Typical Distributors
12.3 Carfilzomib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Carfilzomib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Carfilzomib Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Carfilzomib Product and Services
Table 6. Amgen Carfilzomib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Natco Basic Information, Manufacturing Base and Competitors
Table 8. Natco Major Business
Table 9. Natco Carfilzomib Product and Services
Table 10. Natco Carfilzomib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Carfilzomib Product and Services
Table 14. AstraZeneca Carfilzomib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Carfilzomib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 16. Global Carfilzomib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Carfilzomib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Carfilzomib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 19. Head Office and Carfilzomib Production Site of Key Manufacturer
Table 20. Global Carfilzomib Sales by Region (2016-2021e) & (K Pcs)
Table 21. Global Carfilzomib Sales by Region (2021-2026) & (K Pcs)
Table 22. Global Carfilzomib Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Carfilzomib Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 25. Global Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 26. Global Carfilzomib Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Carfilzomib Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Carfilzomib Price by Type (2016-2021e) & (USD/Pcs)
Table 29. Global Carfilzomib Price by Type (2021-2026) & (USD/Pcs)
Table 30. Global Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 31. Global Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 32. Global Carfilzomib Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Carfilzomib Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Carfilzomib Price by Application (2016-2021e) & (USD/Pcs)
Table 35. Global Carfilzomib Price by Application (2021-2026) & (USD/Pcs)
Table 36. North America Carfilzomib Sales by Country (2016-2021e) & (K Pcs)
Table 37. North America Carfilzomib Sales by Country (2021-2026) & (K Pcs)
Table 38. North America Carfilzomib Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Carfilzomib Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 41. North America Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 42. North America Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 43. North America Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 44. Europe Carfilzomib Sales by Country (2016-2021e) & (K Pcs)
Table 45. Europe Carfilzomib Sales by Country (2021-2026) & (K Pcs)
Table 46. Europe Carfilzomib Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Carfilzomib Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 49. Europe Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 50. Europe Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 51. Europe Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 52. Asia-Pacific Carfilzomib Sales by Region (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Carfilzomib Sales by Region (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Carfilzomib Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Carfilzomib Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 57. Asia-Pacific Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 60. South America Carfilzomib Sales by Country (2016-2021e) & (K Pcs)
Table 61. South America Carfilzomib Sales by Country (2021-2026) & (K Pcs)
Table 62. South America Carfilzomib Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Carfilzomib Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 65. South America Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 66. South America Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 67. South America Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 68. Middle East & Africa Carfilzomib Sales by Country (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Carfilzomib Sales by Country (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Carfilzomib Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Carfilzomib Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Carfilzomib Sales by Type (2016-2021e) & (K Pcs)
Table 73. Middle East & Africa Carfilzomib Sales by Type (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Carfilzomib Sales by Application (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Carfilzomib Sales by Application (2021-2026) & (K Pcs)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Carfilzomib Typical Distributors
Table 79. Carfilzomib Typical Customers
List of Figures
Figure 1. Carfilzomib Picture
Figure 2. Global Carfilzomib Sales Market Share by Type in 2020
Figure 3. 10mg Injection
Figure 4. 30mg Injection
Figure 5. 60mg Injection
Figure 6. Global Carfilzomib Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Drug Center
Figure 10. Other
Figure 11. Global Carfilzomib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Carfilzomib Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Carfilzomib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Carfilzomib Sales (2016-2026) & (K Pcs)
Figure 33. Global Carfilzomib Production Capacity (2016-2026) & (K Pcs)
Figure 34. Global Carfilzomib Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Carfilzomib Market Drivers
Figure 36. Carfilzomib Market Restraints
Figure 37. Carfilzomib Market Trends
Figure 38. Global Carfilzomib Sales Market Share by Manufacturer in 2020
Figure 39. Global Carfilzomib Revenue Market Share by Manufacturer in 2020
Figure 40. Carfilzomib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Carfilzomib Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Carfilzomib Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Carfilzomib Sales Market Share by Region (2016-2026)
Figure 44. Global Carfilzomib Revenue Market Share by Region (2016-2026)
Figure 45. North America Carfilzomib Revenue (2016-2026) & (USD Million)
Figure 46. Europe Carfilzomib Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Carfilzomib Revenue (2016-2026) & (USD Million)
Figure 48. South America Carfilzomib Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Carfilzomib Revenue (2016-2026) & (USD Million)
Figure 50. Global Carfilzomib Sales Market Share by Type (2016-2026)
Figure 51. Global Carfilzomib Revenue Market Share by Type (2016-2026)
Figure 52. Global Carfilzomib Price by Type (2016-2026) & (USD/Pcs)
Figure 53. Global Carfilzomib Sales Market Share by Application (2016-2026)
Figure 54. Global Carfilzomib Revenue Market Share by Application (2016-2026)
Figure 55. Global Carfilzomib Price by Application (2016-2026) & (USD/Pcs)
Figure 56. North America Carfilzomib Sales Market Share by Country (2016-2026)
Figure 57. North America Carfilzomib Revenue Market Share by Country (2016-2026)
Figure 58. North America Carfilzomib Sales Market Share by Type (2016-2026)
Figure 59. North America Carfilzomib Sales Market Share by Application (2016-2026)
Figure 60. Europe Carfilzomib Sales Market Share by Country (2016-2026)
Figure 61. Europe Carfilzomib Revenue Market Share by Country (2016-2026)
Figure 62. Europe Carfilzomib Sales Market Share by Type (2016-2026)
Figure 63. Europe Carfilzomib Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Carfilzomib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Carfilzomib Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Carfilzomib Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Carfilzomib Sales Market Share by Application (2016-2026)
Figure 68. South America Carfilzomib Sales Market Share by Country (2016-2026)
Figure 69. South America Carfilzomib Revenue Market Share by Country (2016-2026)
Figure 70. South America Carfilzomib Sales Market Share by Type (2016-2026)
Figure 71. South America Carfilzomib Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Carfilzomib Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Carfilzomib Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Carfilzomib Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Carfilzomib Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のビンポセチン注射市場 2021：企業別、地域別、種類・用途別 The Vinpocetine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の注射用オマリズマブ市場 2021：企業別、地域別、種類・用途別 The Omalizumab for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のエダラボン注射市場 2021：企業別、地域別、種類・用途別 The Edaravone Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- トリアムシノロンアセトニド注射の世界市場2018-2025 Triamcinolone acetonide is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling. Triamcinolone acetonide injection is for Intra-articular/Intramuscular injection use. In 2018, the global Triamci…
- プロテアソーム阻害剤の世界市場2018-2025 Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins.Proteasome inhibitors are being studied in the treatment of cancer and are used in treating multiple myeloma. In 2018, the global Proteasome Inhibitors market size was xx million US$ and…